urothelial carcinoma
FDA Approves Opdivo Combination for Unresectable or Metastatic Urothelial Carcinoma
The FDA approved nivolumab Opdivo in combination with cisplatin and gemcitabine for first-line treatment of adult ...
MARCH 8, 2024
Balversa Approved for Locally Advanced or Metastatic Urothelial Carcinoma
The FDA approved erdafitinib (Balversa, Janssen Biotech) for adult patients with locally advanced or metastatic ...
JANUARY 22, 2024
Maintenance Rucaparib After Chemo Extends PFS in Some Metastatic Urothelial Cancers
Maintenance therapy with the poly (ADP-ribose) polymerase (PARP) inhibitor rucaparib following platinum-based ...
APRIL 18, 2022
Padcev Granted Regular Approval for Locally Advanced or Metastatic UC
The FDA approved enfortumab vedotin-ejfv (Padcev, Astellas Pharma) to treat some adults with locally advanced or ...
JULY 19, 2021
FDA Approves First FGFR Kinase Inhibitor for Advanced Bladder Ca
The FDA granted accelerated approval to erdafitinib (Balversa, Janssen) for the treatment of adults with locally ...
APRIL 17, 2019
